Serum Galactomannan-Based Early Detection of Invasive Aspergillosis in Hematology Patients Receiving Effective Antimold Prophylaxis

Incidence and Outcome of Invasive Fungal Diseases after Allogeneic Stem Cell Transplantation: A Prospective Study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO)

(2014) Corrado Girmenia et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Prevention of invasive fungal infections in patients with acute myeloid leukaemia: results of a single centre retrospective observational study with the use of posaconazole versus conventional mould-active azoles

(2013) Chiara Maria Dellacasa et al.   JOURNAL OF CHEMOTHERAPY

The management of febrile neutropenia in the posaconazole era: a new challenge?

(2012) L. Pagano et al.   HAEMATOLOGICA

ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients

(2011) O Marchetti et al.   BONE MARROW TRANSPLANTATION

Invasive Aspergillosis Complicating Pandemic Influenza A (H1N1) Infection in Severely Immunocompromised Patients

(2011) C. Garcia-Vidal et al.   CLINICAL INFECTIOUS DISEASES

Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period

(2011) M. R. Ananda-Rajah et al.   HAEMATOLOGICA

Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole vs itraconazole in allogeneic blood and marrow transplantation

(2010) I Sánchez-Ortega et al.   BONE MARROW TRANSPLANTATION

European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update

(2010) J Maertens et al.   BONE MARROW TRANSPLANTATION

Bronchoalveolar Lavage Fluid Galactomannan for Diagnosis of Invasive Pulmonary Aspergillosis

(2010) Bart J. A. Rijnders et al.   CLINICAL INFECTIOUS DISEASES

Detection and investigation of invasive mould disease

(2010) M. Cuenca-Estrella et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Clinical effectiveness of posaconazole prophylaxis in patients with acute myelogenous leukaemia (AML): a 6 year experience of the Cologne AML cohort

(2010) J. J. Vehreschild et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Empirical versus Preemptive Antifungal Therapy for High‐Risk, Febrile, Neutropenic Patients: A Randomized, Controlled Trial

(2009) Catherine Cordonnier et al.   CLINICAL INFECTIOUS DISEASES

Clinically Driven Diagnostic Antifungal Approach in Neutropenic Patients: A Prospective Feasibility Study

(2009) Corrado Girmenia et al.   JOURNAL OF CLINICAL ONCOLOGY

Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America

(2008) Thomas J. Walsh et al.   CLINICAL INFECTIOUS DISEASES

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

(2008) Ben De Pauw et al.   CLINICAL INFECTIOUS DISEASES

Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis

(2008) C. Cordonnier et al.   CLINICAL MICROBIOLOGY AND INFECTION

Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology

(2008) O. A. Cornely et al.   HAEMATOLOGICA